XML 37 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2018
Class of Stock [Line Items]  
Schedule of unrealized gain or loss on derivatives of warrant liability

February 21, 2018 Pre Down Round (Equity)  1,233,086 
Change in Fair Value (deemed dividend)  9,649 
February 21, 2018 Post Down Round (Liability)  1,242,735 
Change in Fair Value  (541,145)
March 31, 2018, ending balance  701,590 
Schedule of key assumptions used model at inception
  February 21, 
2018		  March 31, 
2018		 
       
Stock Price $0.9600  $0.57 
Exercise Price $0.95  $0.95 
Term (years)  5.00   4.90 
Risk Free Rate  2.69%  2.56%
Volatiliy  152.9%  140.4%
Schedule of outstanding stock warrants

  Number of Shares  Average Exercise Price  Expiration Date
Outstanding - December 31, 2017  13,154,872  $2.21   
Granted  5,519,143   0.95  February, 2023
Exercised  (2,500)  1.90   
Outstanding, March 31, 2018  18,671,515  $1.84   
Warrants exercisable at March 31, 2018  18,671,515       
Schedule of the company's stock options
  Number of Shares Underlying Options  Weighted Average Exercise Price  Weighted
Average
Grant Date
Fair Value		  Weighted Average
Remaining
Contractual
Life		  Aggregate Intrinsic 
Value (1)		 
                
Outstanding at December 31, 2017  11,472  $19.35  $4.78   3.61     - 
                     
For the three months ended March 31, 2018                    
Granted  -   -   -   -     
Exercised  -   -   -   -     
Expired  -   -   -   -     
                     
Outstanding at March 31, 2018  11,472  $19.35  $4.78   3.38   - 
                     
Outstanding and Exercisable at March 31, 2017  1,701  $19.35  $4.78   3.38   - 

 

(1)The aggregate intrinsic value is based on the $0.57 closing price as of March 29, 2018 for the Company’s Common Stock.
Schedule of following information applies to options outstanding
Options Outstanding  Options Exercisable 
Exercise Price  Number of Shares Underlying Options  Weighted Average Remaining
Contractual Life		  Number Exercisable  Exercise Price 
$12.00   222   3.38   222  $12.00 
$20.00   11,250   3.38   5,313  $20.00 
     11,472   3.38   5,535    
Series A warrant liability [Member]  
Class of Stock [Line Items]  
Schedule of unrealized gain or loss on derivatives of warrant liability
February 21, 2018 $6,216,073 
Change in Fair Value  (1,716,830)
March 31, 2018 $4,499,243
Series D warrant liability [Member]  
Class of Stock [Line Items]  
Schedule of unrealized gain or loss on derivatives of warrant liability
March 13, 2018 Pre Modification - Equity  1,096,758 
Change in Fair Value due to modification  89,827 
March 13, 2018 Reclass Liability  1,186,585 
Change in Fair Value  (138,207)
March 31, 2018 Fair Value  1,048,378 
Schedule of key assumptions used model at inception
  March 13, 
2018		  March 31, 
2018		 
       
Stock Price $0.64  $0.57 
Exercise Price $0.94  $0.94 
Term (years)  4.50   4.45 
Risk Free Rate  2.62%  2.57%
Volatility  140.4%  140.4%
Series E warrant liability [Member]  
Class of Stock [Line Items]  
Schedule of unrealized gain or loss on derivatives of warrant liability
March 13, 2018 Pre Modification - Equity  2,390,687 
Change in Fair Value due to modification  145,085 
March 13, 2018 Reclass Liability  2,535,772 
Change in Fair Value  (295,226)
March 31, 2018 Fair Value  2,240,546 
Schedule of key assumptions used model at inception
  March 13, 
2018		  March 31, 
2018		 
       
Stock Price $0.64  $0.57 
Exercise Price $0.94  $0.94 
Term (years)  4.58   4.53 
Risk Free Rate  2.62%  2.57%
Volatility  140.4%  140.4%